These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 32391934)

  • 1. 2020 American College of Rheumatology Guideline for the Management of Gout.
    FitzGerald JD; Dalbeth N; Mikuls T; Brignardello-Petersen R; Guyatt G; Abeles AM; Gelber AC; Harrold LR; Khanna D; King C; Levy G; Libbey C; Mount D; Pillinger MH; Rosenthal A; Singh JA; Sims JE; Smith BJ; Wenger NS; Bae SS; Danve A; Khanna PP; Kim SC; Lenert A; Poon S; Qasim A; Sehra ST; Sharma TSK; Toprover M; Turgunbaev M; Zeng L; Zhang MA; Turner AS; Neogi T
    Arthritis Care Res (Hoboken); 2020 Jun; 72(6):744-760. PubMed ID: 32391934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2020 American College of Rheumatology Guideline for the Management of Gout.
    FitzGerald JD; Dalbeth N; Mikuls T; Brignardello-Petersen R; Guyatt G; Abeles AM; Gelber AC; Harrold LR; Khanna D; King C; Levy G; Libbey C; Mount D; Pillinger MH; Rosenthal A; Singh JA; Sims JE; Smith BJ; Wenger NS; Bae SS; Danve A; Khanna PP; Kim SC; Lenert A; Poon S; Qasim A; Sehra ST; Sharma TSK; Toprover M; Turgunbaev M; Zeng L; Zhang MA; Turner AS; Neogi T
    Arthritis Rheumatol; 2020 Jun; 72(6):879-895. PubMed ID: 32390306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current management of gout: practical messages from 2016 EULAR guidelines.
    Nuki G; Doherty M; Richette P
    Pol Arch Intern Med; 2017 Apr; 127(4):267-277. PubMed ID: 28430170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2020 recommendations from the French Society of Rheumatology for the management of gout: Urate-lowering therapy.
    Pascart T; Latourte A; Flipo RM; Chalès G; Coblentz-Baumann L; Cohen-Solal A; Ea HK; Grichy J; Letavernier E; Lioté F; Ottaviani S; Sigwalt P; Vandecandelaere G; Richette P; Bardin T
    Joint Bone Spine; 2020 Oct; 87(5):395-404. PubMed ID: 32422338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gout management: an update].
    Ankli B; Krähenbühl S
    Ther Umsch; 2016; 73(3):115-24. PubMed ID: 27008442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Risk of Gout Flares When Initiating or Escalating Various Urate-Lowering Therapy: A Systematic Review With Network Meta-Analysis.
    Maher D; Reeve E; Hopkins A; Tan JM; Tantiongco M; Ailabouni N; Woodman R; Stamp L; Bursill D; Proudman S; Wiese M
    Arthritis Care Res (Hoboken); 2024 Jun; 76(6):871-881. PubMed ID: 38303574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Gout Flares With the Initiation of Treat-to-Target Allopurinol and Febuxostat: A Post-Hoc Analysis of a Randomized Multicenter Trial.
    Barry A; Helget LN; Androsenko M; Wu H; Kramer B; Newcomb JA; Brophy MT; Davis-Karim A; England BR; Ferguson R; Pillinger MH; Neogi T; Palevsky PM; Merriman TR; O'Dell JR; Mikuls TR
    Arthritis Rheumatol; 2024 Jun; ():. PubMed ID: 38925627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2016 updated EULAR evidence-based recommendations for the management of gout.
    Richette P; Doherty M; Pascual E; Barskova V; Becce F; Castañeda-Sanabria J; Coyfish M; Guillo S; Jansen TL; Janssens H; Lioté F; Mallen C; Nuki G; Perez-Ruiz F; Pimentao J; Punzi L; Pywell T; So A; Tausche AK; Uhlig T; Zavada J; Zhang W; Tubach F; Bardin T
    Ann Rheum Dis; 2017 Jan; 76(1):29-42. PubMed ID: 27457514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying the association between serum urate levels and gout flares in patients taking urate-lowering therapy: a post hoc cohort analysis of the CARES trial with consideration of dropout.
    Tedeschi SK; Hayashi K; Zhang Y; Choi H; Solomon DH
    Ann Rheum Dis; 2024 May; ():. PubMed ID: 38724073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Gout and Hyperuricemia in CKD.
    Vargas-Santos AB; Neogi T
    Am J Kidney Dis; 2017 Sep; 70(3):422-439. PubMed ID: 28456346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).
    Zhang W; Doherty M; Bardin T; Pascual E; Barskova V; Conaghan P; Gerster J; Jacobs J; Leeb B; Lioté F; McCarthy G; Netter P; Nuki G; Perez-Ruiz F; Pignone A; Pimentão J; Punzi L; Roddy E; Uhlig T; Zimmermann-Gòrska I;
    Ann Rheum Dis; 2006 Oct; 65(10):1312-24. PubMed ID: 16707532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing attacks of acute gout when introducing urate-lowering therapy: a systematic literature review.
    Seth R; Kydd AS; Falzon L; Bombardier C; van der Heijde DM; Edwards CJ
    J Rheumatol Suppl; 2014 Sep; 92():42-7. PubMed ID: 25180127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors associated with early gout flare recurrence in patients initiating urate-lowering therapy during an acute gout flare.
    Janssen CA; Oude Voshaar MAH; Ten Klooster PM; Vonkeman HE; van de Laar MAFJ
    Clin Rheumatol; 2019 Aug; 38(8):2233-2239. PubMed ID: 31030363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urate-lowering therapy following a treat-to-target continuation strategy compared to a treat-to-avoid-symptoms discontinuation strategy in gout patients in remission (GO TEST Finale): study protocol of a multicentre pragmatic randomized superiority trial.
    Peeters IR; den Broeder AA; Taylor WJ; den Broeder N; Flendrie M; van Herwaarden N
    Trials; 2023 Apr; 24(1):282. PubMed ID: 37072799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient Perspectives on Gout and Gout Treatments: A Patient Panel Discussion That Informed the 2020 American College of Rheumatology Treatment Guideline.
    Singh JA; Neogi T; FitzGerald JD
    ACR Open Rheumatol; 2020 Dec; 2(12):725-733. PubMed ID: 33222416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Patients with Gout and Kidney Disease: A Review of Available Therapies and Common Missteps.
    Kannuthurai V; Gaffo A
    Kidney360; 2023 Sep; 4(9):e1332-e1340. PubMed ID: 37526648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations.
    Roddy E; Zhang W; Doherty M
    Ann Rheum Dis; 2007 Oct; 66(10):1311-5. PubMed ID: 17504843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2011 recommendations for the diagnosis and management of gout and hyperuricemia.
    Hamburger M; Baraf HS; Adamson TC; Basile J; Bass L; Cole B; Doghramji PP; Guadagnoli GA; Hamburger F; Harford R; Lieberman JA; Mandel DR; Mandelbrot DA; McClain BP; Mizuno E; Morton AH; Mount DB; Pope RS; Rosenthal KG; Setoodeh K; Skosey JL; Edwards NL
    Phys Sportsmed; 2011 Nov; 39(4):98-123. PubMed ID: 22293773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline urate level and renal function predict outcomes of urate-lowering therapy using low doses of febuxostat and benzbromarone: a prospective, randomized controlled study in a Chinese primary gout cohort.
    Liang N; Sun M; Sun R; Xu T; Cui L; Wang C; Ma L; Cheng X; Xue X; Sun W; Yuan X; Zhang H; Li H; He Y; Ji A; Wu X; Li C
    Arthritis Res Ther; 2019 Sep; 21(1):200. PubMed ID: 31477161
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 32.